Kaina B - Search Results

1

Cytotoxic, Genotoxic and Senolytic Potential of Native and Micellar Curcumin.

Beltzig L, Frumkina A, Schwarzenbach C, Kaina B. Beltzig L, et al. Among authors: kaina b. Nutrients. 2021 Jul 13;13(7):2385. doi: 10.3390/nu13072385. Nutrients. 2021. PMID: 34371895 Free PMC article.

2

Effect of ultraviolet light, methyl methanesulfonate and ionizing radiation on the genotoxic response and apoptosis of mouse fibroblasts lacking c-Fos, p53 or both.

Lackinger D, Eichhorn U, Kaina B. Lackinger D, et al. Among authors: kaina b. Mutagenesis. 2001 May;16(3):233-41. doi: 10.1093/mutage/16.3.233. Mutagenesis. 2001. PMID: 11320149

3

The eucalyptus oil ingredient 1,8-cineol induces oxidative DNA damage.

Dörsam B, Wu CF, Efferth T, Kaina B, Fahrer J. Dörsam B, et al. Among authors: kaina b. Arch Toxicol. 2015 May;89(5):797-805. doi: 10.1007/s00204-014-1281-z. Epub 2014 Jun 10. Arch Toxicol. 2015. PMID: 24912782

4

Curcumin Administered as Micellar Solution Suppresses Intestinal Inflammation and Colorectal Carcinogenesis.

Seiwert N, Fahrer J, Nagel G, Frank J, Behnam D, Kaina B. Seiwert N, et al. Among authors: kaina b. Nutr Cancer. 2021;73(4):686-693. doi: 10.1080/01635581.2020.1771384. Epub 2020 May 29. Nutr Cancer. 2021. PMID: 32468854

5

Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells.

Kaina B, Beltzig L, Piee-Staffa A, Haas B. Kaina B, et al. Int J Mol Sci. 2020 Sep 23;21(19):7006. doi: 10.3390/ijms21197006. Int J Mol Sci. 2020. PMID: 32977591 Free PMC article.

6

Molecular Dosimetry of Temozolomide: Quantification of Critical Lesions, Correlation to Cell Death Responses, and Threshold Doses.

Stratenwerth B, Geisen SM, He Y, Beltzig L, Sturla SJ, Kaina B. Stratenwerth B, et al. Among authors: kaina b. Mol Cancer Ther. 2021 Oct;20(10):1789-1799. doi: 10.1158/1535-7163.MCT-21-0228. Epub 2021 Jul 12. Mol Cancer Ther. 2021. PMID: 34253592 Free PMC article.

7

Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment.

Schwarzenbach C, Tatsch L, Brandstetter Vilar J, Rasenberger B, Beltzig L, Kaina B, Tomicic MT, Christmann M. Schwarzenbach C, et al. Among authors: kaina b. Cancers (Basel). 2021 Jul 17;13(14):3585. doi: 10.3390/cancers13143585. Cancers (Basel). 2021. PMID: 34298797 Free PMC article.

8

Accumulation of Temozolomide-Induced Apoptosis, Senescence and DNA Damage by Metronomic Dose Schedule: A Proof-of-Principle Study with Glioblastoma Cells.

Beltzig L, Stratenwerth B, Kaina B. Beltzig L, et al. Among authors: kaina b. Cancers (Basel). 2021 Dec 14;13(24):6287. doi: 10.3390/cancers13246287. Cancers (Basel). 2021. PMID: 34944906 Free PMC article.

9

Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells.

Beltzig L, Schwarzenbach C, Leukel P, Frauenknecht KBM, Sommer C, Tancredi A, Hegi ME, Christmann M, Kaina B. Beltzig L, et al. Among authors: kaina b. Cancers (Basel). 2022 Apr 29;14(9):2233. doi: 10.3390/cancers14092233. Cancers (Basel). 2022. PMID: 35565362 Free PMC article.

10

Temozolomide - Just a Radiosensitizer?

Kaina B, Beltzig L, Strik H. Kaina B, et al. Front Oncol. 2022 Jun 16;12:912821. doi: 10.3389/fonc.2022.912821. eCollection 2022. Front Oncol. 2022. PMID: 35785203 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

324 results

Search Page